Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects

被引:24
作者
Bo, Simona
Ciccone, Giovannino
Pearce, Neil
Merletti, Franco
Gentile, Luigi
Cassader, Maurizio
Pagano, Gianfranco
机构
[1] Univ Turin, Dept Internal Med, I-10126 Turin, Italy
[2] Univ Turin, Unit Canc Epidemiol, CPO, I-10126 Turin, Italy
[3] Univ Turin, CeRMS, I-10126 Turin, Italy
[4] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand
关键词
body mass index (BMI); hyperglycaemia; metabolic syndrome; obesity; physical activity;
D O I
10.1016/j.diabres.2006.06.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To evaluate in the general population the prevalence of undiagnosed metabolic syndrome (MS), defined according to the National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria. Methods: A population-based cross-sectional study of 1175 asymptomatic adults in North-Western Italy. Results: The prevalence of undiagnosed MS was 16.4% (95% Cl = 14.4-18.6) (NCEP) and 28.0% (25.4-30.6) (IDF), respectively, 5.2% (3.6-7.3) and 8.9% (6.6-11.3) in normal-BMI and 26.6% (23.3-30.2) and 45.3% (41.3-49.2) in overweight/obese individuals. Of the total cohort, 52% were overweight/obese and they accounted for 85% of the cases of MS; a further 19% were normal weight with light physical activity and accounted, respectively, for 12% (NCEP) and 13% (IDF) of the cases. Only 25% (NCEP) and 14% (IDF) of participants showed no component of the MS (respectively, 40 and 26% of those not-overweight and 11 and 3% of those overweight/obese). Conclusions: More than 97% of unknown MS cases would be identified among apparently healthy individuals when overweight/ obese, and normal-BMI subjects with low physical activity were screened. These two criteria might, therefore, be used to prioritise screening programmes in asymptomatic subjects, since even apparently healthy individuals, who are not-overweight, frequently show one or more metabolic abnormalities, whose co-existence has been demonstrated to be hazardous. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:362 / 365
页数:4
相关论文
共 11 条
[1]   The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort [J].
Bo, S ;
Gentile, L ;
Ciccone, G ;
Baldi, C ;
Benini, L ;
Dusio, F ;
Lucia, C ;
Forastiere, G ;
Nuti, C ;
Cassader, M ;
Pagano, GF .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) :515-524
[2]   Does C-reactive protein identify a subclinical metabolic disease in healthy subjects? [J].
Bo, S ;
Gambino, R ;
Uberti, B ;
Mangiameli, MP ;
Colosso, G ;
Repetti, E ;
Gentile, L ;
Cassader, M ;
Pagano, GF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (04) :265-270
[3]   Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms [J].
Christensen, J ;
Sandbæk, A ;
Lauritzen, T ;
Borch-Johnsen, K .
DIABETOLOGIA, 2004, 47 (09) :1566-1573
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   The myth of the metabolic syndrome [J].
Gale, EAM .
DIABETOLOGIA, 2005, 48 (09) :1679-1683
[6]  
Gavin JR, 1999, DIABETES CARE, V22, pS5
[7]  
*INT DIAB FED, 2005, IDF CNS WORLDW DEF M
[8]   The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes [J].
Kahn, R ;
Buse, J ;
Ferrannini, E ;
Stern, M .
DIABETES CARE, 2005, 28 (09) :2289-2304
[9]   The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men [J].
Lakka, HM ;
Laaksonen, DE ;
Lakka, TA ;
Niskanen, LK ;
Kumpusalo, E ;
Tuomilehto, J ;
Salonen, JT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (21) :2709-2716
[10]   C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events [J].
Ridker, PM ;
Buring, JE ;
Cook, NR ;
Rifai, N .
CIRCULATION, 2003, 107 (03) :391-397